Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company will host Investor Conference Call on Wednesday, November 1, 2023 at 12 noon (IST) for Q2FY24. Details of the Investor Conference Call are enclosed. Mankind Pharma Ltd - 543904 - Change In Senior Management Personnel
Change in Senior Management Personnel Mankind Pharma Ltd - 543904 - Intimation Of Resumption Of Operations At The Company''s Manufacturing Facility At Sikkim
Intimation of resumption of operations at the Company''s manufacturing facility at Sikkim Mankind Pharma Ltd - 543904 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of Board of Directors of the Company will be held on Tuesday, October 31, 2023, inter-alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended on September 30, 2023. Further, in continuation of our earlier letter dated September 27, 2023 under subject 'Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s ''Code of Conduct for Prevention of Insider Trading'', the trading window for trading in the securities of the Company shall remain closed till November 02, 2023. The above notice and details are also being uploaded on the website of the Company at www.mankindpharma.com. Mankind Pharma Ltd - 543904 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith a copy of the certificate received from KFin Technologies Limited, the Registrar and Transfer Agent of the Company for the quarter ended September 30, 2023. Mankind Pharma Ltd - 543904 - Intimation Of Disruptions Of Operations At The Company'S Manufacturing Facilities At Sikkim Due To Flash Floods
Disruption of operations at the Company''s manufacturing facilities at Sikkim due to flash floods Mankind Pharma Ltd - 543904 - Closure of Trading Window
Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s Code of Conduct for Prevention of Insider Trading Mankind Pharma Ltd - 543904 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results and Consolidated Scrutiniser''s Report of the 32nd Annual General Meeting of Mankind Pharma Limited Mankind Pharma Ltd - 543904 - Intimation Of Commencement Of Commercial Operations At Udaipur Plant
Intimation of commencement of commercial operations at Udaipur Plant Mankind Pharma Ltd - 543904 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 32nd Annual General Meeting ("AGM") of Mankind Pharma Limited ("the Company")